Professor Mark Good
Prosiectau fel Prif Ymchwiliwr
- An evaluation of steric hindrance of APP processing by 2B12 as a treatment for amyloid-related pathology in a preclinical model of Alzheimer's disease (04.01.2008 - 30.09.2011)
- Assessment of AT1R antibody (24.05.2023 - 25.11.2023)
- Does probiotic use influence brain and behaviour (01.01.2010 - 31.12.2012)
- Exploring ACE-2 as a novel therapeutic target for Alzheimer's disease (01.07.2016 - 30.06.2019)
- Exploring ACE-2 as a novel therapeutic target for Alzheimer's disease (01.07.2021 - 30.06.2022)
Prosiectau fel Cyd-Ymchwiliwr
- Attention and Predictive Learning (01.01.2010 - 30.06.2013)
- Determination of the affinity of the potential therapeutic antibody for Alzheimer's disease, 2B3, for amyloid precursor protein (01.03.2014 - 30.06.2014)
- Dietary intervention for Alzheimer's disease: The molecular basis for beneficial effects of omega-3 fatty acids (01.10.2005 - 28.02.2011)
- Ensuring quality maternal care in an adverse environment (01.01.2017 - 31.12.2019)
- Integrated Neuroscience (01.10.2014 - 30.09.2019)